Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03242655 · ClinicalTrials.gov registry record · NA
HCV Group Evaluation and Treatment Uptake (HCV GET-UP) Intervention
A NA study of Hepatitis C and Substance Use Disorders, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
- 1
- Study location
NCT03242655 is a NA study of Hepatitis C and Substance Use Disorders that has completed, run by Montefiore Medical Center. The registered enrollment target is 96 participants, below the 1,889-participant average among 106 other Hepatitis C trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03242655, a NA study of Hepatitis C and Substance Use Disorders, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
People who inject drugs (PWID) represent the overwhelming majority of both HCV and HIV/HCV infected people in the United States. Though new, direct-acting HCV medications are highly efficacious and have the potential to end the HCV epidemic, few PWIDs ever initiate treatment. This study seeks to improve HCV treatment uptake and cure among HCV and HIV/HCV+ PWIDs by testing a primary care based HCV Group Evaluation and Treatment UPtake (GET-UP) intervention. If efficacious, this innovative care intervention could provide a means to reduce the growing mortality from HCV, as well as decrease the current reservoir for HCV transmission.
Conditions Studied
Interventions
- BEHAVIORAL HCV GET-Up (Group Evaluation and Treatment Uptake)
Study Locations (1)
New York
- Comprehensive Health Care Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2017-02-21 |
| Est. Completion | 2020-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03242655
The ClinicalTrials.gov registry entry for NCT03242655 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,889-participant average among 106 other Hepatitis C trials with a reported enrollment target (95% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hepatitis C appearing as the primary indexed condition, and to 1 intervention - of which HCV GET-Up (Group Evaluation and Treatment Uptake) is the first listed.
NCT03242655 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03242655 about?
NCT03242655 is a clinical study titled "HCV Group Evaluation and Treatment Uptake (HCV GET-UP) Intervention". People who inject drugs (PWID) represent the overwhelming majority of both HCV and HIV/HCV infected people in the United States. Though new, direct-acting HCV medications are highly efficacious and have the potential to end the HCV epidemic, few PWIDs ever initiate treatment. This study seeks to imp...
What is the current status of trial NCT03242655?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2017-02-21. Estimated completion is 2020-10-30.
What conditions does trial NCT03242655 study?
This clinical trial studies the following conditions: Hepatitis C, Substance Use Disorders.
What interventions are being tested in trial NCT03242655?
The interventions under investigation include: HCV GET-Up (Group Evaluation and Treatment Uptake) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03242655?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03242655 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
HCV Tappt Adherence Study
RECRUITING · NA
-
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
RECRUITING · NA
-
Buprenorphine Integration Research and Community Health
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.